Start main page content

Research

The Division of Nuclear Medicine collaborates with different entities:

  • LIF-IRIS TB study, 2017-2019: U Pennsylvania, Emory & Aurum Institute-Wits
  • HDT TB study, 2018-2019: Aurum Institute USA & Aurum-Wits
  • INCAPS, 2016-2017: Multicenter (core lab in Vienna, Austria)
  • Deep HYPER-DL study for reduction of radiation dose using artificial intelligence: United Imaging Healthcare, Shanghai & Texas

 

Abstracts presented at Academic Meetings

International:

  • Third Theranostic World congress on Ga-68 and Radiopeptide therapy: 12-14, March 2015 Baltimore, Maryland, USA:
    • PET/CT imaging of neuroendocrine tumors with the use of radiolabelled peptide analogues: the role of 68Ga-DOTATATE.
    • Joining the theranostics league: preliminary data from the Johannesburg early experience.
    • Lutetium-177 (177Lu) dosimetry in patients treated for neuroendocrine tumors (NETs) in Johannesburg, South Africa.
  • Sixteenth World Conference on Lung Cancer: 6-9 September, 2015 Denver, Colorado, USA
    • 18FDG PET/CT Evaluation of Non-Small Cell Lung Cancer- Initial Experience from Johannesburg.
    • 18FDG PET/CT Studies in patients with suspected or confirmed Lung Cancer.
  •  International PET/CT congress (IPET 2015): 5-9 October, 2015 Vienna, Austria
    • 18F-FDG PET/CT imaging has a place in patients with germ cell tumours.
    • 18F-FDG PET/CT imaging in differentiated thyroid carcinoma patients who present with ‘Truncated Expression of Sodium Iodide Symporter’ syndrome.
    • The Role of 68Ga- DOTATATE PET/CT Imaging in Patients with ‘Known’ vs ‘Suspected to Have’ Neuroendocrine Tumours.
    • Audit of F18FDG PET/CT in the assessment of cancer of unknown primary in South Africa
    • Is Cardiac PET Imaging for Viability Assessment an Unnecessary Luxury in Developing Countries?
    • 18F- FDG PET-CT Imaging of Patients with Extra-Cranial Primary Cancer: Routine or Elective Inclusion of Brain in the “Whole Body” Protocol?
    • PET/CT Imaging in Takayasu’s Arteritis – Should It be the Standard of Reference?
  • Ninth European Symponsium of Pediatric Nuclear medicine, 5-8, May 2016 Platja D’Aro, Girona, Spain:
    • Do findings on DISIDA correlate with the final diagnosis in infants presented with Cholesthasis?
    • The incidence of abnormal patterns on Gastroesopheal Scintigraphy (Milk Scan) in a University Hospital in Johannesburg.
    • Patterns of Diuretic Renography in African Patients.
    • Should PET/CT imaging become the modality of choice in Takayasu Disease?
  • Sixty-third Annual meeting of the Society of Nuclear Medicine and Molecular Imaging. San Diego, 11-15 June 2016:
    • Lithium enhanced radioactive iodine ablation of hyperthyroidal patients.
    • SPECT Brain imaging in HIV infected individuals with new first onset Seizures.
  • International Association for the study of Lung Cancer (IASLC): October 15-18, 2017, Yokohama, Japan:
    • Can lymph nodes visualised on PET/CT predict the outcome of patients with Lung cancer?
    • Characteristics of primary lung cancer on PET/CT imaging in South African population.
  • International Conference on Nuclear Cardiology and Cardiac CT (ICNC) 2017 in Vienna, Austria.
    • Resting MPI SPECT as a potential gate keeper for 18F-FDG PET viability studies.
  • Sixty-second Annual meeting of the Society of Nuclear Medicine and Molecular Imaging. Denver, Colorado, USA, 10-14 June 2017
    • Does the use of attenuation corrected SPECT or SPECTCT add any incremental value over the use of non-attenuation corrected SPECT in an older subset of oncology patients?
  • 12th World Congress of the World Federation of Nuclear Medicine and Biology, Melbourne, Australia, 20-24 April 2018
    • Impact of SPECT/CT imaging in oncology – a selection of cases.
    • Comparing planar to SPECT ventilation p-perfusion (VQ) scintigraphy.
    • Thyroid cancer clinic-should serum calcium monitoring become a routine part of follow-up of patients receiving I-131 ablation/treatment?
  • Sixty-third Annual meeting of the Society of Nuclear Medicine and Molecular Imaging. Philadelphia, USA, 23-26 June 2018:
    • Lung ventilation scintigraphy - what is the ideal radioaerosol?
    • 18F-FDG PET/CT in locally advanced cervical cancer- patterns of nodal disease in Sub Saharan Africa.
    • HIV positive patients with locally advanced cervical cancer: Is characterization of FDG PET/CT positive lymph nodes useful.
  • Thirty-six Annual meeting of the European Association of Nuclear Medicine and molecular imaging. Dusseldorf, Germany, 13-17 October 2018.
    • Does HIV status impact on nodes visualized on 18F-FDG PET/CT in patients with invasive cervical carcinoma?
    • Mapping of 18F-FDG PET/CT patterns of tuberculosis in a sub-Saharan region
    • Role of 18F-FDG PET-CT in the differentiation of nodal involvement in patients with Tuberculosis with or without HIV infection.
  • Thirty-second Annual meeting of the European Society of Hyperthermic Oncology. Berlin, Germany, 16-19, May 2018
    • Survival of cervical cancer patients with or without associated HIV infection and treated with modulated electro-hyperthermia combined with chemo-radiotherapy.
  • Sixty-fourth Annual meeting of the Society of Nuclear Medicine and Molecular Imaging. Anaheim, USA, 22-25 June 2019
    • Imaging with PSMA: which approach when only Tech rather than Galli is available?
    • Patients’ awareness of nuclear medicine studies: the impact of the SNMMI value initiative in Johannesburg, South Africa.
    • Correlation of F-18 FDG PET/CT as a novel metabolic parameter with lung impairment and or harmful inflammation during early treatment of pulmonary TB co-infected by HIV.

National:

  • 16th Biennial Congress of the South African Society of Nuclear Medicine, 2016, Pretoria
    • Don’t abandon 99mTc-Tin-Colloid studies for localization of a lower gastro-intestinal bleed just yet!
    • Do findings on Ventilation/Perfusion lung scans correlate with clinical risks? - The CH Baragwanath Hospital Audit
    • Effects of TSH levels on treatment outcomes in patients with differentiated thyroid cancer?
    • Patters of indications and findings of radionuclide thyroid scintigraphy in our clinical settings
    • The correlation between PSA, Gleason score and bone scan findings
    • Myocardial perfusion SPECT imaging in dextrocardia with situs inversus: rare but real
    • Advanced metastatic medullary thyroid carcinoma and variable uptake of I-123 MIBG, Ga-68 DOTATATE and F-18-FDG: A case report
    • Gangrenous leg in a patient with diabetes on MDP bone scintigraphy
    • A conceptual framework to facilitate the assessment of myocardial perfusion imaging quality
    • Impact of late presentation of differentiated thyroid cancer in clinical stage and prognosis of disease: CMJAH experience
    • The ability of SPECT/CT in the localization of ectopic parathyroid adenoma
    • Risk stratification for recurrence and treatment outcome of differentiated thyroid cancer in Johannesburg: An appraisal of the 2015 ATA guidelines from the 2009 edition

 

  • 15th Biennial Congress of the South African Society of Nuclear Medicine, 2018
    • Management of differentiated thyroid cancer- Beyond the 2015 American Thyroid Association Guideline
    • Pros and cons of nuclear medicine information system: Is Venous beautiful?
    • Imaging of a rare case of small cell neuroendocrine tumor of the vulva
    • Is Tc-99m Nanocolloid a good substitute for performing milk scans?
    • Are all that glitters contamination?
    • Strategies to facilitate nuclear medicine radiographers’ practices in the processing and assessment of myocardial perfusion image quality
Share